Loading resource…

Centers for Disease Control and Prevention, Office of Infectious Diseases, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of Tuberculosis Elimination
The guidelines address the complexities of treating patients with both HIV and tuberculosis, emphasizing the importance of managing drug interactions between antiretrovirals and tuberculosis medications. It includes recommendations for various patient populations, including adults, children, and pregnant women. The document also discusses the role of rifamycins in tuberculosis treatment and provides specific recommendations for co-administering antiretroviral drugs with rifampin and rifabutin.
No account needed
Answers use this document only.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Consolidated Guidelines for the Prevention and Treatment of HIV and Aids in Uganda
Same clinical topic · Infectious Disease

Malaria in Pregnancy Prevention and Control Guidelines
Same clinical topic · Infectious Disease

Antimicrobial Prescribing Guidance for Common Infections
Same clinical topic · Infectious Disease

WHO HIV Clinical Management Guidelines
Same clinical topic · Infectious Disease

Guidelines for the treatment of tungiasis
Same clinical topic · Infectious Disease

Cholera Outbreak Detection and Response Guidelines
Same clinical topic · Infectious Disease

MANAGEMENT OF HIV IN PREGNANCY
Same clinical topic · Infectious Disease

NATIONAL GUIDELINES FOR THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS
Same clinical topic · Infectious Disease

Uganda National Malaria Control Policy 2011
Same clinical topic · Infectious Disease